Patents by Inventor Sian Tomiko Taylor

Sian Tomiko Taylor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-(-3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-'1,3,4-OXADIAZOL-2-YL!PHENYL)PYRIDINE-3 SULPHONAMIDE AS AN ANTICANCER AGENT
    Publication number: 20110003831
    Abstract: The use of N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide, or a pharmaceutically acceptable salt thereof, in the treatment of cancer and/or pain in a warm blooded animal such as man is described.
    Type: Application
    Filed: September 13, 2010
    Publication date: January 6, 2011
    Applicant: ASTRAZENECA AB
    Inventors: David Williams Tonge, Sian Tomiko Taylor, Francis Thomas Boyle, Andrew Mark Hughes, Donna Johnson, Marianne Bernice Ashford, Nigel Charles Barrass
  • N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-?1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent
    Patent number: 7820679
    Abstract: The use of N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide, or a pharmaceutically acceptable salt thereof, in the treatment of cancer and/or pain in a warm blooded animal such as man is described.
    Type: Grant
    Filed: August 20, 2003
    Date of Patent: October 26, 2010
    Assignee: AstraZeneca AB
    Inventors: David William Tonge, Sian Tomiko Taylor, Francis Thomas Boyle, Andrew Mark Hughes, Donna Johnstone, Marianne Bernice Ashford, Nigel Charles Barrass